BioSpace News Archive

SIGA Technologies, Inc. today announced that the U.S. Department of Defense (DoD) awarded a new contract to SIGA for the procurement of up to $10.7 million of oral TPOXX.

Annovis Bio announced today that it will present at the Ladenburg Thalmann 2022 Healthcare Conference on Thursday, September 29, 2022, in New York City.

Wellbeing Digital Sciences Inc. announces that Najla Guthrie, CEO of Wellbeing, will participate in the Cantor Fitzgerald Mental Health Clinics Symposium to be held virtually on October 11, 2022 at 9:00 a.m. ET.

Lisata Therapeutics, Inc. announced that Erkki Ruoslahti, M.D., Ph.D., the scientific founder of the Company’s CendR Platform™ technology and a member of the Company’s board of directors, was a recipient of the 2022 Albert Lasker Basic Medical Research Award, which was awarded on September 28, 2022.

Genetic Technologies Limited is delighted to announce the recent publication of a paper in the Journal of Precision Medicine authored by GTG science team members, Dr Erika Spaeth, Director of Clinical Affairs, Dr Richard Allman, Chief Scientific Officer, and Dr Gillian Dite, Senior Biostatistician.

Tenaya Therapeutics, Inc. announced today that it is scheduled to participate in the Hypertrophic Cardiomyopathy Medical Society’s (HCMS) inaugural 2022 Scientific Sessions taking place September 30, 2022, virtually and in National Harbor, MD.

CSL Seqirus, a business of CSL Limited, announced new data from two Canadian studies investigating influenza vaccination uptake, perceptions about influenza, and the importance of vaccination.

As part of their well-established partnership, the United Nations Institute for Training and Research and Takeda, a global pharmaceutical leader and an active member of the United Nations Global Compact, are pleased to announce a new joint initiative focused on strengthening countries’ healthcare systems to meet patients’ need for plasma and plasma-derived therapies.

Genialis , a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced an update to its ResponderID platform, including major innovations to its data flywheel that optimizes the interoperability of datasets for disease modeling.

ImmunoGen, Inc. today announced several data presentations for mirvetuximab soravtansine (mirvetuximab) at the 2022 International Gynecologic Cancer Society (IGCS) Annual Global Meeting in New York City.